In GBM, SQLE was identified to be lowly expressed in temozolomide-resistant glioma cells and involved in the ERK-mediated temozolomide resistance of glioma cells, while overexpression of SQLE significantly inhibited the migration and invasion of tumor cells [115]. This evidence concerns the gene SQLE and neoplasm.